Motor Fluctuations in a Real-World Sample of Patients with Parkinson’s Disease
Objective: To characterize OFF and ON times in a real-world sample of patients with Parkinson’s disease (PD) experiencing motor fluctuations (MF) with carbidopa/levodopa (CD/LD) and…Advance Care Planning in Parkinson’s Disease – Are we getting it right?
Objective: The initial aim of the study was to determine the utilisation of Advance Care Plans in people with Idiopathic Parkinson’s Disease (IPD) and Atypical…Differential impact of Lewy body disease and Alzheimer’s disease neuropathology on cognition
Objective: To examine the impact of Lewy body disease neuropathology (LBD) on domain-specific cognitive impairment in isolation and in combination with Alzheimer’s disease neuropathologic change…The dual cognitive syndrome in Parkinson’s disease: volumetric, morphological and tractometric features
Objective: To assess volumetric, morphological and tractometric features associated with the fronto-striatal and posterior cortical cognitive profiles in Parkinson’s Disease (PD) Background: The dual syndrome…Correlation of brain activity measured using quantitative electroencephalography and cognitive function in patients with de novo Parkinson’s disease
Objective: We performed an exploratory analysis of the correlation of brain activity measured using qEEG and early cognitive function in patients with de novo PD.…Short digitalized cognitive test help differentiating Parkinson’s disease (PD) patients with and without Mild Cognitive Impairment (MCI)
Objective: We explored the capacity of a new digitalized multi-domain cognitive battery, to differentiate PD patients with MCI from those without MCI. Background: MCI is…Predictors of different progressive trajectories of cognition in Parkinson’s disease
Objective: To identify subgroups of people living with Parkinson’s disease (PD) who have statistically distinct trajectories of Montreal Cognitive Assessment (MoCA) scores over four years,…Multimodal EEG-MRI based machine learning model in identifying Parkinson’s disease with mild cognitive impairment
Objective: To evaluate the diagnostic value of quantitative electroencephalogram (qEEG) and structure Magnetic resonance (sMR) in identifying mild cognitive impairment in Parkinson’s disease (PD-MCI) via…Moderately frequent and private variants in PRKN are associated with late-onset Parkinson’s disease
Objective: We hypothesized that heterozygosity for rare coding variants in PRKN, PINK1 or PARK7 might also represent a risk factor for sporadic late-onset PD.[4] Background:…Association of Interleukin (IL)-2 and IL2RA gene polymorphisms with Parkinson’s disease in Taiwan
Objective: The purpose of this study is to investigate if interleukin 2 (IL-2) and interleukin 2 receptor alpha (IL2RA) genes are associated with Parkinson’s disease…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.